SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors aggressively position ahead of its quarterly earnings release, with significant debate surrounding the stock's massive short interest and the potential for a short squeeze if management delivers strong guidance. Community discourse is heavily focused on the company's competitive standing in the AI infrastructure sector, with bulls highlighting strategic partnerships while bears continue to cite concerns over infrastructure bottlenecks and aggressive valuations.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending after reporting strong fiscal earnings and issuing aggressive forward revenue guidance that significantly outpaced analyst expectations, signaling robust demand for its AI infrastructure. Investors are actively debating the stock's potential for a short squeeze as community members emphasize the company's record backlog and management's decision to suspend planned share dilution despite ongoing skepticism regarding governance and competitive pressure.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is rallying following a strong earnings report that highlighted triple-digit revenue growth and a massive, expanding backlog that signals robust AI infrastructure demand. While the community is actively debating the company's heavy capital expenditures and debt load versus its potential as a critical AI compute provider, bullish sentiment is being fueled by a potential short squeeze as investors weigh the company's aggressive growth against broader sector trends.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia Corp is experiencing heightened volatility and intense investor focus as the market awaits a pivotal court ruling regarding its patent litigation, which remains a key catalyst for the stock. The community is actively debating the impact of the ongoing legal battle versus the drug's strong commercial launch and potential market share expansion in the pulmonary hypertension space.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as retail investors and the broader community anticipate significant earnings results following a series of new contract wins and strategic defense partnerships. Shareholders are actively monitoring high short interest and speculating on potential upside volatility, with many hoping for a massive short squeeze during upcoming trading sessions.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing heightened volatility and intense social media discussion as investors debate the impact of preliminary earnings, project delays at its G2 Austin facility, and ongoing concerns regarding capital financing. Despite these headwinds, the community remains divided, with many long-term bulls viewing current price levels as a significant discount and pointing to rising energy demand for AI data centers as a key long-term catalyst.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing significant market attention following positive topline Phase 3 results for its DT120 program, which met primary and secondary endpoints in treating major depressive disorder. The community is actively debating the stock's valuation and potential dilution risks after an upsized equity offering was announced alongside the trial success, with many long-term investors highlighting the drug's upcoming catalysts in generalized anxiety disorder as the next critical milestone.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is surging following strong Q2 earnings that surpassed expectations, highlighted by a significant revenue boost and a raised full-year guidance as demand for its metal 3D printing technology accelerates in the defense and aerospace sectors. Community sentiment remains aggressively bullish, with investors actively discussing potential short squeezes and a massive growth phase fueled by the company's manufacturing capacity expansion.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies is currently drawing investor attention as it navigates a volatility-driven pullback, with many in the community viewing recent price action as a disconnect from improving fundamentals and the company's clear path toward profitability by 2027. Investors are actively discussing the long-term potential of the African e-commerce sector, with sentiment bolstered by strategic partnerships and a focus on operational efficiency, even as broader market instability and geopolitical concerns keep near-term sentiment cautious.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining significant attention as investors anticipate its upcoming earnings report, with community focus centering on the company's strong government contract pipeline and diversified revenue streams from quantum sensing and precision timing. While the broader quantum sector experiences volatility, sentiment remains largely bullish due to recent institutional accumulation and the company's comparative undervaluation relative to its peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?

Biodesix (BDSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Wall Street Analysts Think Biodesix (BDSX) Could Surge 31.91%: Read This Before Placing a Bet

The consensus price target hints at a 31.9% upside potential for Biodesix (BDSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates

Biodesix (BDSX) delivered earnings and revenue surprises of +17.44% and +2.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

BIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

bioAffinity and Biodesix pursue different cancer diagnostics strategies, but which oncology stock offers better long-term upside? Let's dive in.

What's Making Tenet Healthcare Stock Stand Out Right Now?

THC is gaining on rising admissions, strong ambulatory care growth and earnings momentum. But can it sustain gains as expenses keep climbing?

Can Elevance Recover $115 Million Through Its CMS Lawsuit?

ELV seeks to recover an estimated $115 million through a CMS lawsuit over Medicare Advantage Star Ratings and disputed bonus payments.

Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026

Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.

Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform

BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.

Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?

Biodesix (BDSX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Biodesix, Inc. operates as a diagnostic solutions company. It engages in providing blood-based diagnostic tests and development services. The firm offers five diagnostic tests, including Nodify CDT, Nodify XL2, GeneStrat ddPCR, GeneStrat NGS, and VeriStrat. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BDSXBiodesix Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest BDSX News